Warburg Pincus to Acquire Majority Stake in GTCR's Sterigenics
March 24, 2015
Warburg Pincus has agreed to recapitalize contract sterilization company Sterigenics in partnership with existing backer GTCR. Warburg will reportedly acquire a majority stake in a deal that values the company at over $2 billion, including debt. J.P. Morgan will provide debt financing for the transaction, which is expected to close in 2Q. Sterigenics, acquired by GTCR for $675 million in 2011, added three companies to its platform last year: Nordion, FTSI and Gammarad.